{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:52:55Z","timestamp":1791273175829,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.lungcan.2026.109551","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:00:44Z","timestamp":1785340844000},"page":"109551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Associated factors regarding systemic anticancer therapy use prior to death among patients with metastatic non-small cell lung cancer: A multicentre retrospective cohort study"],"prefix":"10.1016","volume":"219","author":[{"given":"Kiki","family":"Mokkenstorm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salom\u00e9","family":"van Beusekom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1064-4762","authenticated-orcid":false,"given":"Camille","family":"Breukhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelinde","family":"Veldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd","family":"Pustjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9282-8208","authenticated-orcid":false,"given":"Nynke","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4202-2985","authenticated-orcid":false,"given":"Maartje","family":"Bos-Gerkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kunst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Geerse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lungcan.2026.109551_b0005","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1200\/JCO.2003.03.059","article-title":"Identifying potential indicators of the quality of end-of-life cancer care from administrative data","volume":"21","author":"Earle","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109551_b0010","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1200\/JCO.24.00542","article-title":"Palliative care for patients with cancer: ASCO guideline update","volume":"42","author":"Sanders","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109551_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100225","article-title":"Care of the adult cancer patient at the end of life: ESMO clinical practice guidelines","volume":"6","author":"Crawford","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.lungcan.2026.109551_b0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2340\/1651-226X.2024.22139","article-title":"Anticancer therapy at end-of-life: a retrospective cohort study","volume":"63","author":"Singh","year":"2024","journal-title":"Acta Oncol."},{"issue":"9","key":"10.1016\/j.lungcan.2026.109551_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103683","article-title":"Systemic anticancer therapy near the end of life: an analysis of factors influencing treatment in advanced tumor disease","volume":"9","author":"Le","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.lungcan.2026.109551_b0030","article-title":"Understanding provision of chemotherapy to patients with end stage cancer: qualitative interview study","volume":"342","author":"Buiting","year":"2011","journal-title":"BMJ"},{"issue":"23","key":"10.1016\/j.lungcan.2026.109551_b0035","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1200\/JCO.2007.15.8253","article-title":"Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?","volume":"26","author":"Earle","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109551_b0040","doi-asserted-by":"crossref","unstructured":"E. Akhlaghi, R.H. Lehto, M. Torabikhah, H. Sharif Nia, A. Taheri, E. Zaboli, A. Yaghoobzadeh, Chemotherapy use and quality of life in cancer patients at the end of life: an integrative review, Health Qual Life Outcomes 2020 Okt 7; 18(1):332.","DOI":"10.1186\/s12955-020-01580-0"},{"issue":"23","key":"10.1016\/j.lungcan.2026.109551_b0045","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70450","article-title":"Novel systemic anticancer therapy and healthcare utilization at the end of life: a retrospective cohort study","volume":"13","author":"Garg","year":"2024","journal-title":"Cancer Med."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109551_b0050","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jpainsymman.2019.11.026","article-title":"Care and decision-making at the end of life for patients with a non-western migration background living in the netherlands: a nationwide mortality follow-back study","volume":"59","author":"Torensma","year":"2020","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.lungcan.2026.109551_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107800","article-title":"Palliative care integration and end-of-life care intensity for patients with NSCLC","volume":"192","author":"Martin","year":"2024","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.lungcan.2026.109551_b0060","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic non-small-cell lung cancer","volume":"363","author":"Temel","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109551_b0065","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3390\/curroncol29030112","article-title":"Palliative systemic therapy given near the end of life for metastatic non-small cell lung cancer","volume":"29","author":"Beaudet","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.lungcan.2026.109551_b0070","unstructured":"IKNL \/ Palliactief. Kwaliteitskader Palliatieve Zorg Nederland. Palliaweb 2017."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:26:02Z","timestamp":1791271562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226006124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":14,"alternative-id":["S0169500226006124"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109551","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associated factors regarding systemic anticancer therapy use prior to death among patients with metastatic non-small cell lung cancer: A multicentre retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109551"}}